NCT07914738
A Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Pharmacokinetics (PK): Maximum Observed Plasma Concentration (Cmax) of LY3819469
Timeframe: Day 1 through Day 15
PK: Area Under the Concentration versus Time Curve (AUC) of LY3819469
Timeframe: Day 1 through Day 15
Arms and interventions
LY3819469 (Upper Arm)Experimental
Administered subcutaneously (SC) in the upper arm
LY3819469 (Thigh)Experimental
Administered SC in the thigh
LY3819469 (Abdomen)Experimental
Administered SC in the abdomen
Drugs: LY3819469